|
 |
| MARKET WATCH |
| Foreign drug makers seek to dominate Indian market again |
As pressure mounts on the pharmaceutical industry to increase revenue, multinational companies (MNCs) are adopting various strategies to increase access to the Indian market, forcing it into a “back-to-the-future mode”, according to global management consultancy and technology outsourcing firm Accenture. |
 |
|
Tt |
|
 |
| |
|
|
| BIOTECH |
| Stage set for bigger biotechnology play by local companies |
Homegrown Cipla has joined the growing list of pharmaceutical companies that intend to manufacture and market biotechnology products. |
|
|
Tt |
|
|
| |
|
|
| STRATEGY |
| Russia to spend $4 bln on pharma industry by 2020 |
Russia is planning to pump 120 billion roubles ($4 billion) into its fledgling pharmaceutical sector this decade as part of a broader push to diversify the economy from oil and gas. |
|
|
Tt |
|
|
| |
|
|
| DRUG DISCOVERY |
| GW Pharmaceuticals to roll world's first cannabis drug |
The cannabis-based drug Sativex, has been discovered for treating symptoms of multiple sclerosis, and has now been approved in Britain , the same has lifted the GW Pharma's shares by 11pc to a four-year high of 141p. |
|
|
Tt |
|
|
| |
|
|
| GENERICS |
| Glenmark targets US oral contraceptives |
Having consolidated in niche segments such as dermatology and extended release drugs in the US, Glenmark Pharmaceuticals, which had revenues of over Rs 1,000 crore in 2009-10, has now set its sights on the US oral contraceptives (hormones) segment. |
|
|
Tt |
|
|
| |
|
|
| NEW THERAPY |
| ELDER PHARMACEUTICALS FORAYS INTO NRT SEGMENT |
Setting its sights onto the Rs 720 crore market for smoking cessation products or nicotine replacement therapy (NRT) products, the Rs 700 cr Elder Pharmaceuticals Ltd (NSE: ELDERPHARM) has entered into an exclusive manufacturing tie-up with M/s Gelnova Laboratories of Navi Mumbai to introduce for the first time in world NRT products in pastille form. |
|
|
Tt |
|
|
| |
|
|
| DEAL WATCH |
| Piramal Healthcare will buy Canadian firm's assets |
Leading Pharmaceutical Company of the country, Piramal Healthcare has announced that it is going to sign an agreement with BioSyntech of Canada. Both the companies have agreed on this deal and as per the current agreement, Piramal Healthcare is going to acquire BioSyntech's assets. |
|
|
Tt |
|
| |
Contact:
enquiry@newmediacomm.biz
New Media Communication Pvt Ltd,
New Media House, 1 Akbar Villa,
Near Old State Bank,
Marol-Maroshi Road, Andheri (East), Mumbai 400 059. (INDIA)
Tel: +91-22-2925 5279/ 2920 1999 |
|
|
|
Readers
can contribute Articles, Reports, Case Studies, Success Stories,
Advertorials besides formal Advertisements. |
|
Disclaimer:
Since India has no anti-spamming law, we follow the US directive passed
in Bill.1618 Title III by the 105th US Congress, which states that mail
cannot be considered spam if it contains contact information, which this
mail does. This mail is not a Spam Mail. In case you do not wish to receive
mails (unsubscribe), kindly send a mail to susheela@newmediacomm.biz |
